World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 20 November 2023
Main ID:  NCT02531087
Date of registration: 20/08/2015
Prospective Registration: Yes
Primary sponsor: Baylor College of Medicine
Public title: Urinary Biomarkers of OI Pathobiology
Scientific title: Cross-Linked Collagen Peptides as a Urinary Biomarker of OI Pathobiology
Date of first enrolment: September 2015
Target sample size: 25
Recruitment status: Active, not recruiting
URL:  https://clinicaltrials.gov/ct2/show/NCT02531087
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
Canada United States
Contacts
Name:     David Eyre, Ph.D.
Address: 
Telephone:
Email:
Affiliation:  University of Washington
Name:     Frank Rauch, M.D.
Address: 
Telephone:
Email:
Affiliation:  Shriners Hospital for Children
Name:     Vernon Reid Sutton, M.D.
Address: 
Telephone:
Email:
Affiliation:  Baylor College of Medicine
Key inclusion & exclusion criteria

Inclusion Criteria:

- To be able to participate, you must:

Be enrolled in The Longitudinal Study of OI (NTC #02432625) and have one of the following
genetic mutations:

- glycine substitution mutations in COL1A1 or COL1A2

- haploinsufficient mutation in COL1A1 or COL1A2

- mutations in CRTAP, PPIB, or LEPRE1

- mutations in FKBP10 or SERPINH1

- mutations in (SERPINF1, WNT1, or IFITM5)

- dominant negative glycine substitutions and haploinsufficient mutations in COL1A1, and
COL1A2

If you are serving as a control, you must not be related to an individual with OI.

Exclusion Criteria:

- You cannot participate if:

- You are unable to comply with the sample collection schedule.

- You are related to one of the OI subjects and would like to serve as a control
subject.

- You have vertebral instrumentation or spinal deformities where we cannot assess lumbar
spine aBMD.

- You have a history of recent fracture (< 3 months).

- You have serum creatinine above 1x upper limits of normal.

- You have abnormal kidney function.

- You are using Minoxidil.

- You are unable to provide a urine sample readily.



Age minimum: N/A
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Osteogenesis Imperfecta
Intervention(s)
Primary Outcome(s)
HP/LP Ratio [Time Frame: 5 Years]
Secondary Outcome(s)
HP/LP ratio [Time Frame: 5 Years]
Secondary ID(s)
37358
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Shriners Hospitals for Children
University of Nebraska
University of Washington
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history